相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel nanoparticle formulation for sustained paclitaxel delivery
W. J. Trickler et al.
AAPS PHARMSCITECH (2008)
Immunotherapy with dendritic cells for cancer
Alberto Ballestrero et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer
Boris A. Hadaschik et al.
BJU INTERNATIONAL (2008)
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care
Vincent Launay-Vacher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Enhanced functionality of CD4+CD25highFoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer
Junko Yokokawa et al.
CLINICAL CANCER RESEARCH (2008)
Epstein-Barr virus-associated epithelial and mesenchymal neoplasms
Andrea T. Deyrup
HUMAN PATHOLOGY (2008)
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Jong-Ho Kim et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes
Kazunari Kondo et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
The use of chitosan formulations in cancer therapy
Crispin R. Dass et al.
JOURNAL OF MICROENCAPSULATION (2008)
Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads
Deanne L. V. Greenwood et al.
VACCINE (2008)
Advances in Chemotherapy for Non–Small Cell Lung Cancer
Elizabeth S. Waxman
Seminars in Oncology Nursing (2008)
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Weihsu Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Nanotechnology safety concerns revisited
Stephan T. Stern et al.
TOXICOLOGICAL SCIENCES (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
DNA vaccines for cervical cancer: from bench to bedside
Chien-Fu Hung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Lifestyle-related factors and environmental agents causing cancer: An overview
P. Irigaray et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles
Xue-Qing Zhang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer
Randeep Sangha et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
Mary T. Litzinger et al.
BLOOD (2007)
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
Derek T. O'Hagan
EXPERT REVIEW OF VACCINES (2007)
Stealth and non-stealth nanocapsules containing camptothecin: In-vitro and in-vivo activity on B16-F10 melanoma
Gecioni Loch-Neckel et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides
Noha Nafee et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
Veronica Mata-Haro et al.
SCIENCE (2007)
Generation of chimeric HBc proteins with epitopes in E.coli:: Formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo
Yan Zhang et al.
CELLULAR IMMUNOLOGY (2007)
Induction of tumor antigen-specific cytotoxic T cell responses in naive mice by latex microspheres-based artificial antigen-presenting cell constructs
Chuanlai Shen et al.
CELLULAR IMMUNOLOGY (2007)
Infectious agents as causes of non-Hodgkin lymphoma
Eric A. Engels
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Multivariate toxicity screening of liposomal formulations on a human buccal cell line
Gro Smistad et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
Deirdre O'Mahony et al.
CLINICAL CANCER RESEARCH (2007)
In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate:: A candidate antigen for treating prostate cancer
Maria de la Luz Garcia-Hernandez et al.
CANCER RESEARCH (2007)
Poly-L-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Gabriela Minigo et al.
VACCINE (2007)
A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients
Ryan D. Cassaday et al.
CLINICAL CANCER RESEARCH (2007)
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus
Patricia L. Mottram et al.
MOLECULAR PHARMACEUTICS (2007)
New developments in the understanding of immunology in silicosis
Francois Huaux
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine
Wenxin Sun et al.
IMMUNOLOGY AND CELL BIOLOGY (2006)
Saponin-adjuvanted particulate vaccines for clinical use
Caroline D. Skene et al.
METHODS (2006)
Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products
Afzal R. Mohammed et al.
METHODS (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
Abdejabar El Andaloussi et al.
NEURO-ONCOLOGY (2006)
CpG motifs as adjuvant in DNA vaccination against Chlamydophila psittaci in turkeys
K Loots et al.
VACCINE (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
How bacteria and their products provide clues to vaccine and adjuvant development
G Dougan et al.
VACCINE (2006)
Reduction in fine particulate air pollution and mortality - Extended follow-up of the Harvard six cities study
F Laden et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens
HJ Qin et al.
IMMUNOLOGY (2006)
Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells
X Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Systemic immune responses in sheep, induced by a novel nano-bead adjuvant
JPY Scheerlinck et al.
VACCINE (2006)
Development of new polymer-based particulate systems for anti-glioma vaccination
A Sapin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Virus-like particles: Designing an effective AIDS vaccine
Kelly R. Young et al.
METHODS (2006)
Virus-like particles production in green plants
Luca Santi et al.
METHODS (2006)
Microparticle-based technologies for vaccines
Derek T. O'Hagan et al.
METHODS (2006)
Liposomal vaccines - targeting the delivery of antigen
Joseph G. Altin et al.
METHODS (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses
L Pelkmans
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
P Attia et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
C Foged et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Vaccination with BLP25 lipsome vaccine to treat non-small cell lung and prostate cancers
Scott North et al.
EXPERT REVIEW OF VACCINES (2005)
Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies
G Kaul et al.
PHARMACEUTICAL RESEARCH (2005)
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood
LA Pinto et al.
VACCINE (2005)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LL Villa et al.
LANCET ONCOLOGY (2005)
ISCOM™-based vaccines:: The second decade
MT Sanders et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
M Schnurr et al.
BLOOD (2005)
Acute pulmonary toxicity caused by exposure to colloidal silica: Particle size dependent pathological changes in mice
T Kaewamatawong et al.
TOXICOLOGIC PATHOLOGY (2005)
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ T-cell-mediated immunity and protection against NY-ESO-1+ tumors
E Maraskovsky et al.
CLINICAL CANCER RESEARCH (2004)
Platinum-based chemotherapy in metastatic breast cancer: current status
MP Decatris et al.
CANCER TREATMENT REVIEWS (2004)
Vaccines that facilitate antigen entry into dendritic cells
A Gamvrellis et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Health effects of particles in ambient air
AD Kappos et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus
CF Crouch et al.
VACCINE (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression
B Birebent et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Challenges facing adjuvants for cancer immunotherapy
C Mesa et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice
T Fifis et al.
VACCINE (2004)
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
IH Frazer et al.
VACCINE (2004)
Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines
SR Little et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
QY Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge
AK Kohli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types
LC Renwick et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2004)
Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis
HJ Dean et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2003)
Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo
S Garg et al.
NATURE IMMUNOLOGY (2003)
Advances in vaccine adjuvants for infectious diseases
M Singh et al.
CURRENT HIV RESEARCH (2003)
Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice
YP Luo et al.
VACCINE (2003)
Recent advances in veterinary vaccine adjuvants
M Singh et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells
M Oelke et al.
NATURE MEDICINE (2003)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
The role of soluble components in ambient fine particles-induced changes in human lungs and blood
YCT Huang et al.
INHALATION TOXICOLOGY (2003)
Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with β-amyloid
DH Cribbs et al.
INTERNATIONAL IMMUNOLOGY (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages
L Thiele et al.
PHARMACEUTICAL RESEARCH (2003)
A two-component modular approach for enhancing T-cell activation utilizing a unique anti-Fc gamma RI-streptavidin construct and microspheres coated with biotinylated-antigen
MC Walsh et al.
BIOMOLECULAR ENGINEERING (2003)
Freund adjuvant induces TLR2 but not TLR4 expression in the liver of mice
SK Lim
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Interactions between ultrafine particles and transition metals in vivo and in vitro
MR Wilson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Cross-presentation of cell-associated antigens by CD8α+ dendritic cells is attributable to their ability to internalize dead cells
O Schulz et al.
IMMUNOLOGY (2002)
Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro
MEC Lutsiak et al.
PHARMACEUTICAL RESEARCH (2002)
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection
M Kumar et al.
HUMAN GENE THERAPY (2002)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo
KD Newman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
Design and selection of vaccine adjuvants: animal models and human trials
CR Alving
VACCINE (2002)
Mechanisms of stimulation of the immune response by aluminum adjuvants
H HogenEsch
VACCINE (2002)
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
EY Woo et al.
JOURNAL OF IMMUNOLOGY (2002)
Protective immune responses elicited in mice by immunization with formulations of poly (lactide-co-glycolide) microparticles
U McKeever et al.
VACCINE (2002)
Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response
V Molinier-Frenkel et al.
JOURNAL OF VIROLOGY (2002)
Recent developments in adjuvants for vaccines against infectious diseases
DT O'Hagan et al.
BIOMOLECULAR ENGINEERING (2001)
Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines
DM Brown et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L Thiele et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Polymers in drug delivery
O Pillai et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants
K Peter et al.
VACCINE (2001)
A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers
H Toledo et al.
VACCINE (2001)
Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids
CC Bowman et al.
INFECTION AND IMMUNITY (2001)
Natural zeolite clinoptilolite: new adjuvant in anticancer therapy
K Pavelic et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM™ vaccines and conventional vaccines
GF Rimmelzwaan et al.
VACCINE (2000)
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
G De Becker et al.
INTERNATIONAL IMMUNOLOGY (2000)
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea
B Genton et al.
VACCINE (2000)
分享论文
